Table 5.
Groups | n | Mean | SD | SE | χ 2 | P value of Kruskal–Wallis ANOVA |
---|---|---|---|---|---|---|
C baseline | ||||||
1 | 13 | 3.84 | 0.482 | 0.134 | 0.424 | 0.809# |
2 | 13 | 3.78 | 0.318 | 0.088 | ||
3 | 13 | 3.82 | 0.462 | 0.128 | ||
Total | 39 | 3.82 | 0.416 | 0.067 | ||
C 9 months | ||||||
1 | 13 | 3.63 | 0.496 | 0.137 | 32.099 | 0.000** |
2 | 13 | 1.12 | 0.117 | 0.032 | ||
3 | 13 | 0.77 | 0.214 | 0.059 | ||
Total | 39 | 1.84 | 1.327 | 0.213 |
Group 1: OFD + placebo; Group 2: OFD + ABG + PRF; Group 3: OFD + ABG + PRF + RSV. OFD: Open flap debridement; ABG: Autogenous bone graft; PRF: Platelet-rich fibrin; RSV: 1.2 mg rosuvastatin gel; n: Number of patients; C: Radiographic width of bone defect; SD: Standard deviation; SE: Standard error